Financials

  • Market Capitalization 9.78 B
  • Employee 273
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-35.28
Relación precio/flujo de caja
106.17

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
914
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
60.43 USD+0.12%-4.62%+14.76%-16.21%10.04 B USD
916
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
78.57 USD-0.08%-1.47%+6.33%+98.18%9.99 B USD
920
CYTK
Cytokinetics, Incorporated - Common Stock
70.23 USD-0.96%-10.41%-8.42%+20.88%9.76 B USD
924
PRAX
Praxis Precision Medicines, Inc. - Common Stock
354.22 USD+1.12%-4.65%+17.71%+685.41%9.89 B USD

Noticias